Search clinical trials for: risperidone (Risperdal)

Total 482 results

National Institute of Mental Health (NIMH)

Completed

CATIE-Alzheimer's Disease Trial

Alzheimer's Disease

United States
Shanghai Mental Health Center
Shanghai Jiao Tong University School of Medicine

Not yet recruiting

Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

Schizophrenia

China
Sykehuset Innlandet HF
Demensforbundet, Norway

Completed

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

Dementia

Norway
Abbott

Completed

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Schizophrenia

United States
Alexandria University

Recruiting

Correlation of Genetic Variations With Clinical Response in Substance Use Disorder

Substance Use Disorders | Substance Dependence

Egypt
Central Institute of Mental Health, Mannheim
University of Cologne

Completed

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (CBD-IS)

Schizophrenia

Germany
Northwell Health
National Institute of Mental Health (NIMH)

Completed

Treatment and Outcome of Early Onset Bipolar Disorder

Bipolar Disorder

United States
University of Pittsburgh

Completed

Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study

Bipolar Disorder

United States
Tianjin Medical University General Hospital
Shanghai Mental Health Center; Nanjing Medical University; First Affiliated Hospital... and other collaborators

Unknown

Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals

Schizophrenia | Anxiety Disorders | Major Depressive Disorder

China
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

Schizophrenia | Schizoaffective Disorder | First Episode Psychosis

United Kingdom
Janssen Research & Development, LLC

Completed

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Immunoassay | Antipsychotic

Belgium
Shanghai Mental Health Center

Unknown

Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime

Schizophrenia

China
Janssen Research & Development, LLC

Terminated

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Schizophrenia | Schizoaffective Disorder

United States
Janssen Research & Development, LLC

Completed

A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

Healthy

Belgium
Eli Lilly and Company

Terminated

A Long-Term, Open-Label, Study on Schizophrenia

Schizophrenia

United States, Puerto Rico, Russian Federation, Mexico, Taiwan, Japan, Korea, Republic of, Ukraine, Croatia
Sykehuset Innlandet HF
Ullevaal University Hospital; University of Bergen; Diakonhjemmet Hospital; Alesund... and other collaborators

Completed

Dementia Antipsychotics And Antidepressants Discontinuation Study (DESEP)

Dementia

Norway
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Completed

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Schizophrenia and Schizoaffective Disorder

Hungary, United States, Argentina, Canada, Czech Republic, Estonia, France, Latvia, Lithuania
University of New Mexico
Patient-Centered Outcomes Research Institute; Montana State University; National... and other collaborators

Terminated

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Bipolar Disorder

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Withdrawn

Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Burkitt Lymphoma | Refractory Burkitt... and other conditions

United States
Technical University of Munich

Completed

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Schizophrenia | Schizoaffective Disorders | Schizophrenia and Disorders With Psychotic Features

Germany
Sultan Qaboos University

Not yet recruiting

Efficacy of Hydroxyzine for Patients With Panic Disorder

Panic Disorder
Janssen Scientific Affairs, LLC

Completed

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) (FIRST)

Schizophrenia

United States
Fundación Pública Andaluza Progreso y Salud
Instituto de Salud Carlos III

Unknown

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (NONSTOP)

Psychosis Nos/Other

Spain
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Antipsychotics and Risk of Hyperglycemic Emergencies

Psychotic Disorders | Diabetes Mellitus, Type 2 | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

Canada
Hospital Universitari de Bellvitge

Terminated

Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression

Depression

Spain
University of Southern California
National Cancer Institute (NCI)

Recruiting

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Plasma Cell Myeloma

United States, Puerto Rico
Abdullah Khan

Terminated

Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Hospital de Clinicas de Porto Alegre

Unknown

Interpersonal Psychotherapy for Treatment Resistant Depression

Treatment Resistant Depression

Brazil
National Cancer Institute (NCI)

Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular... and other conditions

United States
Duke University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

Heart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditions

United States, Canada
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany

Search clinical trials for: risperidone (Risperdal)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations